Fetal büyümeye etki eden maternal faktörler

1.
Ör
s R, Dilmen U. Fetal fizyoloji. İçerisinden: Kişnişçi H.A, Gökşin E, Durukan T, Üstay K, Ayhan A, Gürgan T ve ark. Temel kadın hastalıkları ve doğum bilgisi. Güneş kitabevi Ankara-1996, 205-213
2.
Varo
l FG, Sayın NC. Fetal büyüme. İçerisinden: Beksaç MS, Demir N, Koç A, Yüksel A. Obstetrik maternal fetal tıp ve perinatoloji. MN medikal nobel Ankara-2001, 1040-1054
3.
Demi
r SC, Evrüke C, Kadayıfçı O. Perinatal mortalite ve morbidite. İçerisinden: Beksaç MS, Demir N, Koç A, Yüksel A. Obstetrik maternal fetal tıp ve perinatoloji. MN medikal nobel Ankara-2001, 1194-1211
4. Verrier M, Spears W, Ying J, Kerr GR. Patterns of birth weight in relation to gestational age, maternal age, parity, and prenatal care in Texas' triethnic population, 1984 through 1986. Tex Med. 1993; 89(12):51-6.
5. Amarin VN, Akasheh HF. Advanced maternal age and pregnancy outcome. East Mediterr Health J. 2001 7(4-
5):646-51.
6. Ekwo EE, Moawad A. Maternal age and preterm births in a black population. Paediatr Perinat Epidemiol. 2000; 14(2):145-51.
7. Feleke Y, Enquoselassie F. Maternal age, parity and gestational age on the size ofthe newborn in Addis Ababa. East Afr Med J. 1999; 76(8):468-71.
8. Barbara A. Maternal nutrition. In: Robert K.C, Robert R. Maternal-fetal medicine. Third edition. W. B. saunders company. Philadelphia-1994, 162-170
9. Orskou J, Henriksen TB, Kesmodel U, Secher NJ. Maternal characteristics and lifestyle factors and the risk of delivering high birth weight infants. Obstet Gynecol. 2003; 102(1):115-20.
10. Dang K, Homko C, Reece EA. Factors associatedwith
fetal macrosomia in offspring ofgestational diabetic women. J Matern Fetal Med. 2000; 9(2):114-7.
11. Naeye R.L, et all, Maternal nutrition and fetal growth. NutrRev. 1974; 32(8):241-3.
12. Molina M, Casanueva V, Perez R, Ferrada C, Cisternas J, Cid L, Saez K. Impact ofhypertensive disease of pregnancy on intrauterine growth retardation. Rev Med Chil. 1998; 126(4):375-82.
13. Shapiro C, Sutija VG, Bush J. Effect ofmaternal weight gain on infant birth weight. J Perinat Med.
2000;28(6):428-31.
14. Hobel C, Culhane J. Role ofpsychosocial andnutritional stress on poor pregnancy outcome. J Nutr. 2003;133(5 Suppl 2):1709S-1717S.
15. Villar J, Altobelli L, Kestler E, Belizan J. A health priority for developing countries: the prevention of chronic fetal malnutrition. Bull World Health Organ. 1986;64(6):847-51.
16. Neel NR, Alvarez JO. Maternal risk factors for low birth weight and intrauterine growth retardation in a Guatemalan population. Bull Pan Am Health Organ. 1991;25(2):152-65.
17. Mahajan SD, Singh S, Shah P, Gupta N, Kochupillai N. Effect ofmaternal malnutrition and anemia on the endocrine regulation offetal growth. Endocr Res. 2004; 30(2):189-203.
18. Gambling L, Charania Z, Hannah L, Antipatis C, Lea RG, McArdle HJ. Effect ofiron deficiency on placental cytokine expression and fetal growth in the pregnant rat. Biol Reprod. 2002;66(2):516-23.
19. Zambrano E, Rodriguez-Gonzalez GL, Guzman C, Garcia-Becerra R, Boeck L, Diaz L, et all. Maternal low protein diet during pregnancy and lactation in the rat impairs male reproductive development. J Physiol. 2005; 15;563(Pt 1):275-84.
20. Sondergaard C, Henriksen TB, Obel C, Wisborg K. Smoking during pregnancy and infantile colic. Pediatrics. 2001; 108(2):342-6.
21. Jaakkola JJ, Gissler M. Maternal smoking in pregnancy, fetal development, and childhood asthma. Am J Public Health. 2004; 94(1):136-40.
22. Wisborg K, Henriksen TB, Hedegaard M, Secher NJ. Smoking during pregnancy and preterm birth. Br J ObstetGynaecol. 1996; 103(8):800-5.
23. Backe B. Maternal smoking and age. Effect on birthweight and risk for small-for-gestational age births. Acta Obstet Gynecol Scand. 1993; 72(3):172-6.
24. Kallen K. Maternal smoking during pregnancy and infant head circumference at birth. Early Hum Dev. 2000; 58(3):197-204.
25. Wyszynski DF, Duffy DL, Beaty TH Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate Craniofac J. 1997; 34(3):206-10.
26. Haddow JE, Palomaki GE, Holman MS. Young maternal age and smoking during pregnancy as risk
S.D.Ü. Tıp Fak.
Derg
. 2006:13(2)/ 47-54
Desdicioğlu, Fetal büyüme ve maternal faktörler
53
factors for gastroschisis Teratology. 1993; 47(3):225-
8.
27. Kallen K. Maternal smoking and craniosynostosis. Teratology. 1999; 60(3):146-50.
28. Kallen K. Maternal smoking during pregnancy and limb reduction malformations in Sweden. Am J Public Health. 1997; 87(1):29-32.
29. Kallen K. Maternal smoking and urinary organ malformations. Int J Epidemiol. 1997; 26(3):571-4.
30. Wasserman CR, Shaw GM, O'Malley CD, Tolarova MM, Lammer EJ. Parental cigarette smoking and risk for congenital anomalies ofthe heart, neural tube, or limb. Teratology. 1996; 53(4):261-7.
31. Wisborg K, Henriksen TB, Secher NJ. Maternal smoking and gestational age in twin pregnancies. Acta Obstet Gynecol Scand. 2001; 80(10):926-30.
32. Windham GC, Eaton A, Hopkins B. Evidence for an association between environmental tobacco smoke exposure and birthweight: a meta-analysis and new data. PaediatrPerinatEpidemiol. 1999; 13(1):35-57.
33. Nelson E, Jodscheit K, Guo Y. Maternal passive smoking during pregnancy and fetal developmental toxicity. Part 1: gross morphological effects. Hum Exp Toxicol. 1999; 18(4):252-6.
34. Colak O, Alatas O, Aydogdu S, Uslu S. The effect of smoking on bone metabolism: maternal and cord blood bone marker levels. : Clin Biochem. 2002; 35(3):247-
50.
35. Howard DJ, Briggs LA, Pritsos CA. Oxidative DNA damage in mouse heart, liver, and lung tissue due to acute side-stream tobacco smoke exposure. Arch Biochem Biophys. 1998, 15;352(2):293-7.
36. Zaren B, Lindmark G, Bakketeig L. Maternal smoking affects fetal growth more in the male fetus. Paediatr PerinatEpidemiol. 2000; 14(2):118-26.
37.
Atas
ü T, Benian A. Bağımlılık yapan maddelerin fetusa etkileri. İçerisinden: Atasü T. Gebelikte fetusa ve yenidoğana zararlı etkenler. 2. baskı. Nobel tıp kitapevleri Ankara-2000, 461-476
38. Livy DJ, Maier SE, West JR. Long-term alcohol exposure prior to conception results in lower fetal body weights. Birth Defects Res B Dev Reprod Toxicol. 2004; 71(3):135-41.
39. Neel NR, Alvarez JO. Maternal risk factors for low birth weight and intrauterine growth retardation in a Guatemalan population. Bull Pan Am Health Organ. 1991;25(2):152-65.
40.
Büg
ü B.Ö. Gebelik ve laktasyon döneminde ilaç kullanımı. 5. baskı. Nobel tıp kitapevleri Ankara-2001, 1-1220
41. Frank DA, Zuckerman BS, Amaro H, Aboagye K, Bauchner H, Cabral H, et all. Cocaine use during pregnancy: prevalence andcorrelates. Pediatrics. 1988;
82(6):888-95.
42.
Atas
ü T, Gezer A. Gebelikte ilaç kullanımı. İçerisinden:
Atasü T. Gebelikte fetusa ve yenidoğana zararlı etkenler. 2. baskı. Nobel tıp kitapevleri Ankara-2000, 373-444
43. Taeusch HW Jr. Glucocorticoid prophylaxis for respiratory distress syndrome: a review ofpotential toxicity.JPediatr. 1975; 87(4):617-23.
44. Stenchever MA, Williamson RA, Leonard J, Karp LE, Ley B, Shy K, et all. Possible relationship between in utero diethylstilbestrol exposure and male fertility. Am J Obstet Gynecol. 1981, 15;140(2):186-93.
45. Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring.AmJObstetGynecol. 1982, 1;142(7):905-
21.
46. Gupta C, Sonawane BR, Yaffe SJ, Shapiro BH. Phenobarbital exposure in utero: alterations in female reproductive functioninrats. Science. 1980, 2;208(4443):508-10.
47. Gupta C, Yaffe SJ, Shapiro BH. Prenatal exposure to phenobarbital permanently decreases testosterone and causesreproductivedysfunction. Science. 1982, 7;216(4546):640-2.
48. Van der Pol MC, Hadders-Algra M, Huisjes HJ, Touwen BC. Antiepileptic medication in pregnancy: late effects on the children's central nervous system development. Am J Obstet Gynecol. 1991; 164(1 Pt 1):121-8.
49. Livezey GT, Rayburn WF, Smith CV. Prenatal exposure to phenobarbital and quantifiable alterations in the electroencephalogram of adult rat offspring. Am J ObstetGynecol. 1992; 167(6):1611-5.
50. Mungan
T
. Gebelikte ilaç kullanımı ve teratoloji. İçerisinden: Saraçoğlu F. Fetal tanı ve tedavi. Güneş kitapevi Ankara-1998, 480-496
51. Ayhan A, Yapar EG, Yuce K, Kisnisci HA, Nazli N, Ozmen F. Pregnancy and its complications after cardiac valvereplacement. IntJGynaecolObstet. 1991; 35(2):117-22.
52. Blomberg S. Influence ofmaternal distress during pregnancy on postnatal development. Acta Psychiatr Scand. 1980; 62(5):405-17.
53. Hedegaard M, Henriksen TB, Sabroe S, Secher NJ. Psychological distress in pregnancy andpreterm delivery. BMJ. 1993, 24;307(6898):234-
9.
54. Peacock JL, Bland JM, Anderson HR. Preterm delivery: effects ofsocioeconomic factors, psychological stress, smoking, alcohol, and caffeine. BMJ. 1995, 26;311(7004):531-5.
55. Sjostrom K, Valentin L, Thelin T, Marsal K. Maternal anxiety in late pregnancy: effect on fetal movements and fetal heartrate. Early Hum Dev. 2002; 67(1-2):87-
100
56. Selvaggi L, Diaferia A, Loizzi P, Bettocchi S, Calia C, Moretti A, et all. Effect ofmaternal anxiety (unrest) on the health status of the fetus. Zentralbl Gynakol.
S.D.Ü. Tıp Fak.
Derg
. 2006:13(2)/ 47-54
54
Desdicioğlu, Fetal büyüme ve maternal faktörler
1984;106(23):1528-35.
57. Vaido AI, Shiryaeva NV, Vshivtseva VV. Effect of prenatal stress on proliferative activity and chromosome aberrations in embryo brain in rats with different excitability ofthe nervous system. Bull Exp Biol Med. 2000; 129(4):380-2.
58. Peters DA. Effects ofmaternal stress during different gestational periods on the serotonergic system in adult rat offspring. Pharmacol Biochem Behav. 1988; 31(4):839-43.
59. Hobel C, Culhane J. Role ofpsychosocial andnutritional stress on poor pregnancy outcome. J Nutr. 2003; 133(5 Suppl 2):1709S-1717S
60. LangfordK.S. Infectiousdiseaseandpregnancy. Current obstetric gynaecology 2002, 12 125-130
61.
Kadayıfç
ı O, Ürünsak İ.F, Ürünsak M, Atay Y. Gebelikte enfeksiyon hastalıkları. İçerisinden: Beksaç M.S, Demir N, Koç A, Yüksel A. Obstetrik maternal fetal tıp ve perinatoloji. Medikal nobel Ankara-2001,
878-939
62.
Madazl
ı R, Atasü T. Fetus ve yenidoğana etkili enfeksiyon hastalıkları. İçerisinden: Atasü T. Gebelikte fetusa ve yenidoğana zararlı etkenler. 2. baskı. Nobel tıp kitapevleri Ankara-2000, 319-372
63. McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol. 1996; 103(2):123-9
64. Molina M, Casanueva V, Perez R, Ferrada C, Cisternas J, Cid L, et all. Impact ofhypertensive disease of pregnancy on intrauterine growth retardation. Rev Med Chil. 1998; 126(4):375-82.
65. Gray PH, O'Callaghan MJ, Mohay HA, Burns YR, King JF. Maternal hypertension and neurodevelopmental outcome in very preterm infants. Arch Dis Child Fetal NeonatalEd. 1998; 79(2):F88-93
66. Piper JM, Langer O. Is lung maturation related to fetal growth in diabetic or hypertensive pregnancies? Eur J Obstet Gynecol Reprod Biol. 1993; 51(1):15-9
67.
Özkına
y E, Kazandı M. Preeklampsi. İçerisinden: Beksaç M.S, Demir N, Koç A, Yüksel A. Obstetrik maternal fetal tıp ve perinatoloji. Medikal nobel Ankara-2001, 625-652.
68.
KayaE
. Gebelikhipertansiyonupreeklampsi-eklampsi. İçerisinden: Beksaç M.S, Demir N, Koç A, Yüksel A. Obstetrik maternal fetal tıp ve perinatoloji. Medikal nobelAnkara-2001, 661-675
69. Fernandez Jonusas S, Ceriani Cernadas JM. The effects of arterial hypertension during pregnancy on birth weight, intrauterine growth retardation and neonatal evolution. A matched case-control study. An Esp Pediatr. 1999; 50(1):52-6.
70. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol. 2000; 96(6):950-5.
71. Madazlı R, Ocak V. Diabetik gebelik ve konjenital
anomali ilişkisi. İçerisinden: Atasü T. Gebelikte fetusa ve yenidoğana zararlı etkenler. 2. baskı. Nobel tıp kitapevleri Ankara-2000,585-594
72. Padmanabhan R, Shafiullah M. Effect ofmaternal diabetes and ethanol interactions on embryo development in the mouse. Mol Cell Biochem. 2004;
261(1-2):43-56.
73. Chan BW, Chan KS, Koide T, Yeung SM, Leung MB, Copp AJ, et all. Maternal diabetes increases the risk ofcaudal regression caused by retinoic acid. Diabetes. 2002;51(9):2811-6
74. Xiao D, Ducsay CA, Zhang L. Chronic hypoxia and developmental regulation ofcytochrome c expression in rats. J Soc Gynecol Investig. 2000; 7(5):279-83.
75. Bae S, Xiao Y, Li G, Casiano CA, Zhang L. Effect of maternal chronic hypoxic exposure during gestation on apoptosis in fetal rat heart. Am J Physiol Heart Circ Physiol. 2003; 285(3):983-90.
76. Rees S, Breen S, Loeliger M, McCrabb G, Harding R. Hypoxemia near mid-gestation has long-term effects on fetal brain development. J Neuropathol Exp Neurol. 1999; 58(9):932-45.
77.
Özme
n Ş. Otoimmünhastalıklarve gebelik. İçerisinden: Saraçoğlu F. Fetal tanı ve tedavi. Güneş kitapevi Ankara-1998,613-625
78. Meyer O. Making pregnancy safer for patients with lupus. Joint Bone Spine. 2004; 71(3):178-82.
79.
Özgüne
n T. Fetal maternal travmalar. İçerisinden: Saraçoğlu F. Fetal tanı ve tedavi. Güneş kitapevi Ankara-1998, 577-585
80. Clapp JF 3rd. Exercise and fetal health. J Dev Physiol. 1991; 15(1):9-14
81. Rao S, Kanade A, Margetts BM, Yajnik CS, Lubree H, Rege S. et all. Pune Maternal Nutrition Study. Maternal activity in relation to birth size in rural India. The Pune Maternal Nutrition Study. Eur J Clin Nutr. 2003;57(4):531-42.
82. Jones RD, Morice AH, Emery CJ. Effects ofperinatal exposure to hypoxia upon the pulmonary circulation of the adult rat. Physiol Res. 2004;53(1):11-7
83.
Akarcal
ı İ, Albayrak T, Demirtürk F. Gebelikte egzersiz ve doğum eğitimi. İçerisinden: Beksaç M.S, DemirN, Koç A, Yüksel A. Obstetrik maternal fetal tıp ve perinatoloji. Medikal nobel Ankara-2001, 956-97